199 related articles for article (PubMed ID: 32009574)
1. Preparation and characterization of polylactic-co-glycolic acid/insulin nanoparticles encapsulated in methacrylate coated gelatin with sustained release for specific medical applications.
Akhavan Farid E; Davachi SM; Pezeshki-Modaress M; Taranejoo S; Seyfi J; Hejazi I; Tabatabaei Hakim M; Najafi F; D'Amico C; Abbaspourrad A
J Biomater Sci Polym Ed; 2020 May; 31(7):910-937. PubMed ID: 32009574
[TBL] [Abstract][Full Text] [Related]
2. Biodegradable Nanoparticles-Loaded PLGA Microcapsule for the Enhanced Encapsulation Efficiency and Controlled Release of Hydrophilic Drug.
Ryu S; Park S; Lee HY; Lee H; Cho CW; Baek JS
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801871
[TBL] [Abstract][Full Text] [Related]
3. Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization.
Santander-Ortega MJ; Bastos-González D; Ortega-Vinuesa JL; Alonso MJ
J Biomed Nanotechnol; 2009 Feb; 5(1):45-53. PubMed ID: 20055105
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and in vitro release study of ibuprofen-loaded gelatin graft copolymer nanoparticles.
Haroun AA; El-Halawany NR; Loira-Pastoriza C; Maincent P
Drug Dev Ind Pharm; 2014 Jan; 40(1):61-5. PubMed ID: 23244199
[TBL] [Abstract][Full Text] [Related]
5. Effect of different molecular weight PLGA on flurbiprofen nanoparticles: formulation, characterization, cytotoxicity, and
Öztürk AA; Yenilmez E; Şenel B; Kıyan HT; Güven UM
Drug Dev Ind Pharm; 2020 Apr; 46(4):682-695. PubMed ID: 32281428
[No Abstract] [Full Text] [Related]
6. Design of PLGA nanoparticles for sustained release of hydroxyl-FK866 by microfluidics.
Bai X; Tang S; Butterworth S; Tirella A
Biomater Adv; 2023 Nov; 154():213649. PubMed ID: 37820459
[TBL] [Abstract][Full Text] [Related]
7. Poly-(Lactic-co-Glycolic) Acid Nanoparticles for Synergistic Delivery of Epirubicin and Paclitaxel to Human Lung Cancer Cells.
Sharma N; Kumari RM; Gupta N; Syed A; Bahkali AH; Nimesh S
Molecules; 2020 Sep; 25(18):. PubMed ID: 32947799
[TBL] [Abstract][Full Text] [Related]
8. Development of 6-Thioguanine conjugated PLGA nanoparticles through thioester bond formation: Benefits of electrospray mediated drug encapsulation and sustained release in cancer therapeutic applications.
Chatterjee M; Jaiswal N; Hens A; Mahata N; Chanda N
Mater Sci Eng C Mater Biol Appl; 2020 Sep; 114():111029. PubMed ID: 32994006
[TBL] [Abstract][Full Text] [Related]
9. Anti-proliferate and apoptosis triggering potential of methotrexate-transferrin conjugate encapsulated PLGA nanoparticles with enhanced cellular uptake by high-affinity folate receptors.
Parmar A; Jain A; Uppal S; Mehta SK; Kaur K; Singh B; Sandhir R; Sharma S
Artif Cells Nanomed Biotechnol; 2018; 46(sup2):704-719. PubMed ID: 29745729
[TBL] [Abstract][Full Text] [Related]
10. pH-responsive Astragalus polysaccharides-loaded poly(lactic-co-glycolic acid) nanoparticles and their in vitro immunogenicity.
Xu S; Wusiman A; Liu Z; Gu P; Ni H; Zhang Y; Hu Y; Liu J; Wu Y; Wang D
Int J Biol Macromol; 2019 Mar; 125():865-875. PubMed ID: 30576729
[TBL] [Abstract][Full Text] [Related]
11. Prediction of the enhanced insulin absorption across a triple co-cultured intestinal model using mucus penetrating PLGA nanoparticles.
Jaradat A; Macedo MH; Sousa F; Arkill K; Alexander C; Aylott J; Sarmento B
Int J Pharm; 2020 Jul; 585():119516. PubMed ID: 32525079
[TBL] [Abstract][Full Text] [Related]
12. PEGylated PLGA nanoparticles as protein carriers: synthesis, preparation and biodistribution in rats.
Li Y; Pei Y; Zhang X; Gu Z; Zhou Z; Yuan W; Zhou J; Zhu J; Gao X
J Control Release; 2001 Apr; 71(2):203-11. PubMed ID: 11274752
[TBL] [Abstract][Full Text] [Related]
13. Synergistic induction of apoptosis in lung cancer cells through co-delivery of PLGA phytol/α-bisabolol nanoparticles.
Kiruthiga C; Balan DJ; Prasath NH; Manikandakrishnan M; Jafni S; Prabhu NM; Pandian SK; Devi KP
Naunyn Schmiedebergs Arch Pharmacol; 2024 Jul; 397(7):5131-5144. PubMed ID: 38240783
[TBL] [Abstract][Full Text] [Related]
14. HP55-coated capsule containing PLGA/RS nanoparticles for oral delivery of insulin.
Wu ZM; Zhou L; Guo XD; Jiang W; Ling L; Qian Y; Luo KQ; Zhang LJ
Int J Pharm; 2012 Apr; 425(1-2):1-8. PubMed ID: 22248666
[TBL] [Abstract][Full Text] [Related]
15. Preparation and characterization of gelatin surface modified PLGA microspheres.
Tsung MJ; Burgess DJ
AAPS PharmSci; 2001; 3(2):E11. PubMed ID: 11741261
[TBL] [Abstract][Full Text] [Related]
16. Computational design of Phe-Tyr dipeptide and preparation, characterization, cytotoxicity studies of Phe-Tyr dipeptide loaded PLGA nanoparticles for the treatment of hypertension.
Kecel-Gündüz S; Budama-Kilinc Y; Cakir Koc R; Kökcü Y; Bicak B; Aslan B; Özel AE
J Biomol Struct Dyn; 2018 Aug; 36(11):2893-2907. PubMed ID: 28835169
[TBL] [Abstract][Full Text] [Related]
17. HPMA-PLGA Based Nanoparticles for Effective In Vitro Delivery of Rifampicin.
Rani S; Gothwal A; Pandey PK; Chauhan DS; Pachouri PK; Gupta UD; Gupta U
Pharm Res; 2018 Dec; 36(1):19. PubMed ID: 30511238
[TBL] [Abstract][Full Text] [Related]
18. Development and in vitro characterization of polymeric nanoparticles containing recombinant adrenomedullin-2 intended for therapeutic angiogenesis.
Quadros HC; Santos LMF; Meira CS; Khouri MI; Mattei B; Soares MBP; de Castro-Borges W; Farias LP; Formiga FR
Int J Pharm; 2020 Feb; 576():118997. PubMed ID: 31893542
[TBL] [Abstract][Full Text] [Related]
19. Eudragit
El-Maghawry E; Tadros MI; Elkheshen SA; Abd-Elbary A
Int J Nanomedicine; 2020; 15():3965-3980. PubMed ID: 32606658
[TBL] [Abstract][Full Text] [Related]
20. Nifedipine-loaded polymeric nanoparticles: Preparation and in vitro characterization.
Ozakar E; Cetin M; Ates O; Hacimuftuoglu A
Pak J Pharm Sci; 2019 Mar; 32(2):547-554. PubMed ID: 31081765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
